LTRN news

Latest 3 stories · newest Sep 23, 2026

LTRN
Lantern to present roadmap for AI subsidiary OMAI at live event

Lantern Pharma plans to demonstrate the multi-agentic AI platform withZeta.ai, sharing market and roadmap details during a live session dedicated to Open-Medicine AI.

Leadership Sep 23, 2026 sentiment 0.00 SEC filing ↗
LTRN
Lantern Spin-Outs as Separate AI Company

Lantern has established a separate company, Open-Medicine AI, to commercialize its withZeta.ai platform by licensing technology and assets, aiming to leverage the projected growth in AI drug discovery.

Restructuring Aug 3, 2026 sentiment 0.00 SEC filing ↗
LTRN
Lantern Pharma files 8-K disclosure with exhibit materials

Lantern Pharma Inc. submitted an 8-K filing with SEC containing exhibit materials. The filing lacks specific material information from the provided text excerpt.

Other Jun 1, 2026 sentiment 0.00 SEC filing ↗
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same LTRN feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/LTRN/newsSTART FREE